SCHEMBL38663601

SCHEMBL38663601

CCS(=O)(=O)c1cnc(OC)nc1C(N)=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLAU P00749 2/20 0.35
▸ SIRT6 Q8N6T7 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ CYP1A2 P05177 4/20 0.33
▸ NNMT P40261 2/20 0.33
▸ TP53 P04637 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ NAMPT P43490 1/20 0.33
▸ DYRK1A Q13627 1/20 0.32
▸ DYRK1B Q9Y463 1/20 0.32
▸ FLT1 P17948 1/20 0.32
▸ FLT4 P35916 1/20 0.32
▸ KDR P35968 1/20 0.32
▸ JAK2 O60674 1/20 0.31
▸ JAK1 P23458 1/20 0.31
▸ TYK2 P29597 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38665739 0.85 PLAU (0.36) PLAUSIRT6CYP1A2NNMTLMNA
SCHEMBL38663555 0.80 NPC1 (0.33) MEN1NPC1RAB9AKMT2ATP53
SCHEMBL30103427 0.74 PLAU (0.43) PLAUSIRT6CYP1A2NNMTHPGDS
SCHEMBL18940888 0.71 COMT (0.35) CYP1A2MAPTLMNAALDH1A1CYP3A4
SCHEMBL23629315 0.70 HSD17B10 (0.41) MEN1NPC1RAB9AKMT2AMAPT
SCHEMBL38662970 0.70 NPSR1 (0.41) MEN1NPC1RAB9AKMT2ATP53
SCHEMBL38662973 0.70 NAMPT (0.34) PLAUMEN1NPC1RAB9AKMT2A
SCHEMBL18940882 0.68 CHRM2 (0.37) MEN1NPC1KMT2ACYP1A2TP53
SCHEMBL24912642 0.67 TDP1 (0.38) PLAUMEN1KMT2ACYP1A2MAPT
SCHEMBL18940878 0.66 COMT (0.49) NPC1RAB9ACYP1A2MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026107422-A1 6-(PYRIDIN-4-YL)-1H-BENZO[D]IMIDAZOLE DERIVATIVES AS CAMK2 INHIBITORS FOR THE TREATMENT OF HEART FAILURE BRISTOL-MYERS SQUIBB COMPANY (US) 2026-05-21 — — WO disclosed
Send feedback